BAE Systems plc (BA)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 2,037.00 |
|---|---|
| 52-week range | 1,588.00 – 2,360.00 |
| Return, 1 month / 3 months | +3.3% / +1.8% |
| Return, 1 year / 3 years | +9.3% / +96.1% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 30.4% |
| Worst drawdown (1 year) | -23.1% |
| Average daily value traded | 10,378.23M GBX |
| Dividend yield | 1.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
BAE Systems plc is a defence, security and aerospace company based in the United Kingdom. It designs and builds military aircraft, combat vehicles, naval ships and submarines, and it supplies missiles, electronics and cyber and intelligence services. Its customers are chiefly governments and armed forces, with substantial business in the United States and the United Kingdom alongside other international markets. The company also provides support and maintenance services for the equipment it supplies.
BAE Systems plc trades under the code BA on the London Stock Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
BAE Systems plc (BA) trades on the London Stock Exchange in UK. It last closed at GBX 2,037.00 on 27 October 2026.
Its price-based Market X-Ray is 60 out of 100 (a fair price profile), ranking 1,281 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 9.3% and over the last three months it rose 1.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 0.5% | ||
| From 52-week high | -12.6% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.8% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | 5.8% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.1% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 10,378.23M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.9% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.6% |
|---|---|
| 1 month | +3.3% |
| 3 months | +1.8% |
| 6 months | +0.0% |
| 1 year | +9.3% |
| 3 years | +96.1% |
| 5 years | +304.5% |
Signals
| 50-day / 200-day average | 1,980.95 / 2,027.36 |
|---|---|
| Golden / death cross (60 days) | Death, 8 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 51.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Oct 2026 | GBX 15.0000 |
| 23 Apr 2026 | GBX 22.8000 |
| 23 Oct 2025 | GBX 13.5000 |
| 17 Apr 2025 | GBX 20.6000 |
| 24 Oct 2024 | GBX 12.4000 |
| 18 Apr 2024 | GBX 18.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.